Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
24.02.2016 14:00:00

Materialise to Introduce a Suite of Software and Solutions for 3D Printing in Hospitals at the AAOS Annual Meeting – Booth 3781

Materialise NV (NASDAQ:MTLS) announced today that they will be showcasing a full suite of software and solutions for 3D printing within hospitals at AAOS, the American Association of Orthopaedic Surgeon’s Annual Meeting in Orlando, Florida: March 1-5, booth 3781. Introduced for the first time at the AAOS Annual Meeting, this Suite brings together medical software and services into a neutral platform that facilitates the further integration of 3D planning and printing into hospitals. Also launched as part of the Suite will be a new software solution that enables surgeons to 3D print accurate medical models in hospitals.

Visitors to booth 3781 are invited to discover Materialise Medical’s integrated range of software and solutions, with which hospitals can:

  • Create detailed pre-operative plans from digital x-ray images
  • Master the preparation of files for 3D printing
  • Treat complex cases with 3D-printed anatomical models, and patient-specific guides and implants
  • Integrate virtual planning and 3D printing into their surgical workflow, from straightforward cases to the most complex.

Experts from the Materialise Medical team will be present throughout this year’s AAOS Annual Meeting to answer questions and demonstrate how their platform of software and services can enable surgeons and radiologists to revolutionize patient-specific treatment that helps save and improve lives like never before.

About Materialise
With its headquarters in Leuven, Belgium, and branches worldwide, Materialise is a provider of Additive Manufacturing (AM) software solutions and sophisticated 3D printing services in a wide variety of industries, including healthcare, automotive, aerospace, art and design and consumer products. Materialise has been playing an active role in the field of AM since 1990, through its involvement in AM for industrial and medical applications, by providing biomedical and clinical solutions such as medical image processing and surgical simulations and by developing unique solutions for its customers' prototyping, production, and medical needs. For additional information, please visit: www.materialise.com.

Twitter: @belgiancanuck or @MaterialiseNV
Visit: www.materialise.com

Analysen zu Materialise NV (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Materialise NV (spons. ADRs) 7,05 43,29% Materialise NV (spons. ADRs)